REAUTHORIZATION; REPORTING REQUIREMENTS.

SEC. 204. REAUTHORIZATION; REPORTING REQUIREMENTS. (a) Performance Reports.—Section 738A(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(a)) is amended— (1) in paragraph (1)— (A) in subparagraph (A)— (i) by striking “2013” and inserting “2018”; and (ii) by striking “the Medical Device User Fee Amendments of 2012” and inserting “the Medical Device User Fee Amendments of 2017”; and (B) in subparagraph (B), by striking “the Medical Device User Fee Amendments Act of 2012” and inserting “the Medical Device User Fee Amendments of 2017”; and (2) in paragraph (2), by striking “2013 through 2017” and inserting “2018 through 2022”. (b) Reauthorization.—Section 738A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-1(b)) is amended— (1) in paragraph (1), by striking “2017” and inserting “2022”; and (2) in paragraph (5), by striking “2017” and inserting “2022”.